Metabolic control of type I (insulin dependent) diabetes after pancreas transplantation. 1985

G Pozza, and E Bosi, and A Secchi, and P M Piatti, and J L Touraine, and A Gelet, and A E Pontiroli, and J M Dubernard, and J Traeger

A study was conducted of the circadian hormonal and metabolic patterns of 10 type I (insulin dependent) uraemic diabetic patients after pancreas and renal transplantation. A single 24 hour profile was obtained in each patient following as closely as possible his or her normal daily routine two to 15 months after transplantation. None of the patients were using insulin at the time of the study. Compared with a group of six normal subjects the transplant recipients had mildly raised blood glucose concentrations, hyperinsulinaemia between meals and at night, delayed postprandial insulin peaks, mild hyperketonaemia, and normal blood lactate and plasma glucagon concentrations. The findings showed that successful pancreas transplantation results in disappearance of the need for insulin and return to normal or near normal of the metabolic abnormalities of diabetes. The minor differences observed in comparison with normal hormonal and metabolic homoeostasis were probably due to intrinsic (reduced islet mass, denervation, peripheral hormone delivery) and environmental (immunosuppression, relatively impaired renal function) factors.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D008297 Male Males
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D005260 Female Females
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006885 Hydroxybutyrates Salts and esters of hydroxybutyric acid. Hydroxybutyric Acid Derivatives,Hydroxybutyric Acids,Acid Derivatives, Hydroxybutyric

Related Publications

G Pozza, and E Bosi, and A Secchi, and P M Piatti, and J L Touraine, and A Gelet, and A E Pontiroli, and J M Dubernard, and J Traeger
September 1985, British medical journal (Clinical research ed.),
G Pozza, and E Bosi, and A Secchi, and P M Piatti, and J L Touraine, and A Gelet, and A E Pontiroli, and J M Dubernard, and J Traeger
February 1996, Diabetes,
G Pozza, and E Bosi, and A Secchi, and P M Piatti, and J L Touraine, and A Gelet, and A E Pontiroli, and J M Dubernard, and J Traeger
June 1994, Transplantation proceedings,
G Pozza, and E Bosi, and A Secchi, and P M Piatti, and J L Touraine, and A Gelet, and A E Pontiroli, and J M Dubernard, and J Traeger
October 1983, British medical journal (Clinical research ed.),
G Pozza, and E Bosi, and A Secchi, and P M Piatti, and J L Touraine, and A Gelet, and A E Pontiroli, and J M Dubernard, and J Traeger
January 1992, Journal of diabetes and its complications,
G Pozza, and E Bosi, and A Secchi, and P M Piatti, and J L Touraine, and A Gelet, and A E Pontiroli, and J M Dubernard, and J Traeger
December 1997, Transplantation proceedings,
G Pozza, and E Bosi, and A Secchi, and P M Piatti, and J L Touraine, and A Gelet, and A E Pontiroli, and J M Dubernard, and J Traeger
January 1988, The New England journal of medicine,
G Pozza, and E Bosi, and A Secchi, and P M Piatti, and J L Touraine, and A Gelet, and A E Pontiroli, and J M Dubernard, and J Traeger
August 1991, Diabetologia,
G Pozza, and E Bosi, and A Secchi, and P M Piatti, and J L Touraine, and A Gelet, and A E Pontiroli, and J M Dubernard, and J Traeger
September 1994, Postgraduate medicine,
G Pozza, and E Bosi, and A Secchi, and P M Piatti, and J L Touraine, and A Gelet, and A E Pontiroli, and J M Dubernard, and J Traeger
January 1995, Transplant international : official journal of the European Society for Organ Transplantation,
Copied contents to your clipboard!